Lixte Biotech Holdings (STU:864) Pretax Margin %

: % (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Lixte Biotech Holdings's Pre-Tax Income for the three months ended in Sep. 2022 was €-1.49 Mil. Lixte Biotech Holdings's Revenue for the three months ended in Sep. 2022 was €0.00 Mil. Therefore, Lixte Biotech Holdings's pretax margin for the quarter that ended in Sep. 2022 was %.

The historical rank and industry rank for Lixte Biotech Holdings's Pretax Margin % or its related term are showing as below:

Lixte Biotech Holdings Pretax Margin % Historical Data

The historical data trend for Lixte Biotech Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lixte Biotech Holdings Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Pretax Margin %

Lixte Biotech Holdings Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Pretax Margin %																-	-	-	-	-

Lixte Biotech Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Lixte Biotech Holdings's Pretax Margin for the fiscal year that ended in Dec. 2021 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-5.954280000131	/	0
	=	%

Lixte Biotech Holdings's Pretax Margin for the quarter that ended in Sep. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-1.4927800000015	/	0
	=	%

Lixte Biotech Holdings (STU:864) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Lixte Biotech Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Lixte Biotech Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lixte Biotech Holdings (STU:864) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lixte Biotech Holdings Inc (STU:864) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

LIXT:USA

Address

680 East Colorado Boulevard, Suite 180, Pasadena, CA, USA, 91101

Website

https://www.lixte.com

Lixte Biotech Holdings Inc is a drug discovery company that has a developed unique, proprietary, first-in-class protein phosphatase inhibitor, LB-100, as its lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in combination with standard anti-cancer therapies, including cytotoxic drugs, radiation, and immune checkpoint blockers.

Lixte Biotech Holdings (STU:864) Headlines

No Headlines